Q1 2025 Nu Skin Enterprises Inc Earnings Call
All participants are in a listen only mode. After the speaker's presentation there'll be a question and answer session to ask a question. During the session you will need to press star one on your telephone.
Speaker Change: Didn't hear an automated message advising your hand is raised to Australia. A question. Please press star one again, please be advised that today's conference is being recorded.
Jihad: I would now like to turn the conference over to your speaker for today be Jihad you May go ahead.
Jihad: Thanks, Lisa and good afternoon, everyone I'm joined by Ryan appear ski President and CEO and James Thomas CFO, We're excited to share new skins results from Q1 of 2025.
Speaker Change: Before I turn the time over to Ryan Let me point out that on today's call comments will be made that include forward looking statements.
Speaker Change: These statements involve risks and uncertainties and actual results may differ materially from those discussed or anticipated.
Speaker Change: Please refer today's earnings release, and our SEC filings for a complete discussion of these risks.
Speaker Change: Also during the call certain financial numbers may be discussed that differ from comparable numbers obtained in our financial statements. We believe these non-GAAP numbers assist in comparing period to period results in a more consistent manner. Please.
Speaker Change: Please refer to our Investor website, IR Dot <unk> dot com for any required reconciliation of these non-GAAP numbers.
Unknown Executive: At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you'll need to press star 1, 1 on your. You will then hear an automated message advising your To withdraw your question, please press star 1.
Brian: And with that I'd like now to turn the call over to Brian.
These statements involve risks and uncertainties and actual results may differ materially from those discussed or anticipated.
Brian: Thanks, everyone for joining the call I'll begin with an overview of our Q1 performance and then provide an update on our key priorities for 2025 as we pursue our mission of being a global force for good by empowering people to look feel and live better lives, having just returned from our Japan live event in our Americas success with <unk>.
Please refer today's earnings release, and our SEC filings for a complete discussion of these risks.
Also during the call certain financial numbers may be discussed that differ from comparable numbers obtained in our financial statements. We believe these non-GAAP numbers assist in comparing period to period results in a more consistent manner. Please.
Unknown Executive: Please be advised that today's conference is being recorded.
Unknown Executive: I would now like to turn the conference over to your speaker for today, B.G. Hunt. You may go ahead.
Brian: I am increasingly optimistic about the company's future in spite of near term macro environmental factors as we remained focused on our mission.
B.G. Hunt: Thanks, Lisa, and good afternoon, everyone. I'm joined by Ryan Napierski, President and CEO, and James Thomas, CFO. We're excited to share NU Skin's results from Q1 of 2025.
Please refer to our Investor website, IR Dot <unk> dot com for any required reconciliation of these non-GAAP numbers.
Brian: We have a strong partnership with our amazing sales leaders and experienced management team who are proven to innovate.
B.G. Hunt: Before I turn the time over to Ryan, let me point out that on today's call, comments will be made that include forward looking statements. These statements involve risks and uncertainties, and actual results may differ materially from those discussed or anticipated. Please refer today's earnings release and our SEC filings for a complete discussion of these risks.
And with that I'd like now to turn the call over to Brian. Thanks, Vijay Thanks, everyone for joining the call I'll begin with an overview of our Q1 performance and then provide an update on our key priorities for 2025 as we pursue our mission of being a global force for good by empowering people to look feel and live better lives, having just returned.
Brian: Exercise resilience in the face of challenges.
Brian: We achieved first quarter revenue at the high end of our guidance range due in part to improving business trends in certain markets and exceeded our earnings expectations for adjusted earnings per share as we effectively control expenses around the world.
Brian: We experienced significant growth in Latin America as our developing market strategy continues to take hold in that region. Those gains were offset by the U S and Canada related to the increasing macro pressures on the business. We are pleased to see improving trends in our kpis in both South Korea, and China as we continue to stabilize these.
B.G. Hunt: Also during the call, certain financial numbers may be discussed that differ from comparable numbers obtained in our financial statement. We believe these non-GAAP numbers assist in comparing period-to-period results in a more consistent manner. Please refer to our investor website, ir.nueskin.com, for any required reconciliation of these non-GAAP numbers.
Our Japan live event in our Americas success in Paris, I mean.
Creasing the optimistic about the company's future in spite of near term macro environmental factors as we remained focused on our mission.
Brian: Markets in Europe, and Africa demonstrated improving results related to the implementation of our enhanced sales performance plan and.
Experience Management Team, who have proven to innovate and exercise resilience in the face of challenges.
Ryan Napierski: And with that, I'd like now to turn the call over to Brian. Thanks, BG. Thanks, everyone, for joining the call. I'll begin with an overview of our Q1 performance and then provide an update on our key priorities for 2025 as we pursue our mission of being a global force for good by empowering people to look, feel, and live better lives. Having just returned from our Japan live event and our America's success trip in Paris, I'm increasingly optimistic about the company's future in spite of near-term macro-environmental factors as we remain focused on our mission. We have a strong partnership with our amazing sales leaders and experienced management team who have proven to innovate and exercise resilience in the face of challenge.
We achieve first quarter revenue at the high end of our guidance range, doing part to improving business trends in certain markets and exceeding our earnings expectations for adjusted earnings per share as we effectively control expenses around the world.
Brian: And we were pleased to see growth in several markets in Southeast Asia Pacific, Though Indonesia reported reported additional headwinds during the quarter Japan.
Brian: <unk> remained relatively consistent on a local currency basis as we continue to develop our stable consumer base.
We experience significant growth in Latin America as our developing market strategy continues to take hold in that region. Those gains were offset by the US and Canada related to the increasing macro pressures on the business.
Brian: Our <unk> segments performed well during the quarter with 10% year over year growth in manufacturing and growing interest in life DNA one of our upcoming enterprise innovations that I'm excited to talk with you about as we delve deeper into our intelligent wellness class platform strategy that will speak to in just a moment.
We are pleased to see improving trends in our KPIs in both South Korea and China as we continue to stabilize these important markets and Europe and Africa demonstrated improving results related to the implementation of our enhanced sales performance plan.
Brian: Overall, we continue to experience macroeconomic pressures as consumers remain cautious in their purchasing behaviors for premium beauty and wellness products amid uncertainty around the.
Ryan Napierski: We achieved first quarter revenue at the high end of our guidance range, due in part to improving business trends in certain markets, and exceeded our earnings expectations for adjusted earnings per share as we effectively control expenses around the world. We experienced significant growth in Latin America as our developing market strategy continues to take hold in that region. Those gains were offset by the US and Canada related to the increasing macro pressures on the business. We are pleased to see improving trends in our KPIs in both South Korea and China as we continue to stabilize these important markets, and Europe and Africa demonstrated improving results related to the implementation of our Enhanced Sales Performance Plan.
and we were pleased to see growth in several markets in Southeast Asia Pacific, though Indonesia reported additional headwinds during the quarter. Japan remained relatively consistent on a local currency basis, and we continue to develop our stable consumer base.
Brian: Potential impact of tariffs on inflation and driving down consumer sentiment around the world.
Brian: Looking ahead, you may recall that we outlined three strategic priorities for 2025 first strengthening our core nu skin business.
Our right segments performed well during the quarter with 10% year-over-year growth and manufacturing, and growing interest in life DNA, one of our upcoming enterprise innovations that I'm excited to talk with you about as we delve deeper into our intelligent wellness class platform strategy that I'll speak to in just a moment.
Brian: Accelerating innovation related to our Io intelligent beauty and wellness platform.
Brian: And third improving our operational performance and efficiency.
Brian: Collectively our progress on these priorities will help us continue to move closer towards our long term beauty wellness and lifestyle ecosystem vision, so let's dive deeper into each priority.
Overall, we continue to experience macroeconomic pressures as consumers remain cautious in their purchasing behaviors for premium beauty and wellness products amid uncertainty around the potential impact of tariffs on inflation and driving down consumer sentiment around the world.
Brian: First in terms of strengthening our core business, we remain wholly committed to our mission of empowering people around the world to look feel and live better lives via our rewarding entrepreneurial business opportunity.
Ryan Napierski: And we were pleased to see growth in several markets in Southeast Asia-Pacific, though Indonesia reported additional headwinds during the quarter. Japan remained relatively consistent on a local currency basis as we continue to develop our stable consumer base. Our ride segments performed well during the quarter with 10% year over year growth in manufacturing and growing interest in LifeDNA, one of our upcoming enterprise innovations that I'm excited to talk with you about as we delve deeper into our intelligent wellness platform strategy that I'll speak to in just a moment. Overall, we continue to experience macroeconomic pressures as consumers remain cautious in their purchasing behaviors for premium beauty and wellness products amid uncertainty around the potential impact of tariffs on inflation and driving down consumer sentiment around the world.
Brian: We recently achieved a major milestone that very few companies in our industry ever achieved surpassing $20 billion in sales compensation paid to our sales force while direct selling continues to evolve in terms of the how we do business. The why of our mission is as strong today as it ever has been.
Looking ahead, you may recall that we outlined three strategic priorities for 2025. First, strengthening our core NU Skin Business.
Second, Accelerating Innovation related to our I.O. Intelligent Beauty and Wellness platform and third, Improving our Operational Performance and Efficiency
Brian: We're focused on continuously enhancing our sales compensation plan to more effectively reward our brand affiliates for building their businesses in a social first manner.
Collectively, our progress on these priorities will help us continue to move closer towards our long-term beauty wellness and lifestyle ecosystem vision. So let's dive deeper into each priority.
Brian: While maintaining our commitment to rewarding our global sales leaders for training and motivating their sales teams. Our latest sales performance plan is showing improving trends in South Korea, Europe and Pacific markets, while we continue to optimize it in North America.
First, in terms of strengthening our core business, we remain wholly committed to our mission of empowering people around the world to look, fill, and live better lives via our rewarding entrepreneurial business opportunity.
We recently achieved a major milestone that very few companies in our industry ever achieved, surpassing $20 billion in sales compensation paid to our sales force.
Ryan Napierski: Looking ahead, you may recall that we outlined three strategic priorities for 2025. First, strengthening our core NU Skin business. Second, accelerating innovation related to our IO intelligent beauty and wellness platform. And third, improving our operational performance and efficiency. Collectively, our progress on these priorities will help us continue to move closer towards our long term beauty, wellness and lifestyle ecosystem vision. So let's dive deeper into each priority. First, in terms of strengthening our core business, we remain wholly committed to our mission of empowering people around the world to look, feel and live better lives via our rewarding entrepreneurial business opportunities.
Brian: <unk>, our leadership driven customer obsessed model is critical to ensuring the vibrancy of our business as we look into the future of how consumers are engaging with beauty and wellness brand via social media.
While direct selling continues to evolve in terms of the how we do business, the why of our mission is as strong today as it ever has been.
Brian: We're also strengthening our core business by more assertively pursuing our developing market strategy there.
We're focused on continuously enhancing our sales compensation plan to more effectively reward our brand affiliates for building their businesses in a social first manner, while maintaining our commitment to rewarding our global sales leaders for training and motivating their sales teams.
Brian: This simplified and focused business model is driving strong 144% year on year growth in Latin America, and is driving improved profitability as well as streamline product portfolio priced affordably at retail together with an enhanced compensation plan and a scalable operating infrastructure powered by our dine.
Our latest self-performance plan is showing improving trends in South Korea, Europe and Pacific markets, while we continue to optimize within North America.
Brian: NAMIC group of dedicated sales leaders enables a more focused and profitable approach to growth in the market.
Ryan Napierski: We recently achieved a major milestone that very few companies in our industry ever achieved surpassing $20 billion in sales compensation paid to our sales force. While direct selling continues to evolve in terms of the how we do business, the why of our mission is as strong today as it ever has been. We're focused on continuously enhancing our sales compensation plan to more effectively reward our brand affiliates for building their businesses in a social first manner, while maintaining our commitment to rewarding our global sales leaders for training and motivating their sales. Our latest sales performance plan is showing improving trends in South Korea, Europe and Pacific markets, while we continue to optimize it in North America.
Evolving our leadership driven customer-obsessed model is critical to ensuring the vibrancy of our business as we look into the future of how consumers are engaging with beauty and wellness brand by a social media first.
Brian: We look forward to applying learnings from this model to strength in developing markets in Europe, and Southeast Asia Pacific.
Brian: We will be leveraging these learnings as we expand into India. Later this year, India holds enormous.
We're also strengthening our core business by more assertively pursuing our developing market strategy.
Brian: Mid to long term potential with its $1 4 billion population highly entrepreneurial tendencies and rapidly expanding beauty and wellness industries.
This simplified and focused business model is driving strong 144% year-on-year growth in Latin America and is driving improved profitability as well.
Brian: We plan to enter with a prelaunch for qualified brand representatives in Q4 of this year with a formal market launch to follow in mid 2026, we will enter the market with a suite of locally manufactured beauty and wellness products tailored to India consumer needs in a localized version of our global sales compensation plan that reward.
Ryan Napierski: Evolving our leadership-driven, customer-obsessed model is critical to ensuring the vibrancy of our business as we look into the future of how consumers are engaging with beauty and wellness brands via social media first. We're also strengthening our core business by more assertively pursuing our developing market strategy. This simplified and focused business model is driving strong 144% year-on-year growth in Latin America and is driving improved profitability as well. A streamlined product portfolio priced affordably at retail, together with an enhanced compensation plan and a scalable operating infrastructure, powered by our dynamic group of dedicated sales leaders, enables a more focused and profitable approach to growth in the market.
We look forward to applying learning from this model to strengthen developing markets in Europe and Southeast Asia Pacific.
Brian: <unk>, India and affiliates for the promotion of selling new skin products and building sales teams. We are working with our partners at Infosys to also provide a digital first experience tailored to the unique market dynamics.
Brian: We're excited to answer this rapidly developing market with where micro entrepreneurship is a central driver to their economic growth.
Brian: Our second priority in 2025 is to accelerate innovation with the introduction of Prism Io are truly intelligent wellness platform. We've been preparing for this opportunity for more than 20 years of collective scientific studies and research and development with recent technological advancements in machine learning and artificial intelligence we are now.
We plan to enter it with a pre-launch for qualified brand representatives in Q4 of this year with a formal market launch to follow in mid-2026.
We will enter the market with a suite of locally manufactured beauty and wellness products tailored to India consumer needs and a localized version of our global sales compensation plan that rewards Indian affiliates for the promotion of selling new skin products and building sales teams.
Ryan Napierski: We look forward to applying learnings from this model to strengthen developing markets in Europe and Southeast Asia Pacific. We will be leveraging these learnings as we expand into India later this year. India holds enormous mid to long term potential with its 1.4 billion population, highly entrepreneurial tendencies and rapidly expanding beauty and wellness industries. We plan to enter with a pre-launch for qualified brand representatives in Q4 of this year, with a formal market launch to follow in mid-2026. We will enter the market with a suite of locally manufactured beauty and wellness products tailored to India consumer needs, and a localized version of our global sales compensation plan that rewards Indian affiliates for the promotion of selling NU Skin products and building sales teams. We are working with our partners at Infosys to also provide a digital-first experience tailored to the unique market dynamic.
Brian: Reaching a point of enabling us to realize this vision with in a more integral way that will enhance our ability to develop even deeper relationships with our consumers.
We are working with our partners at Infosys to also provide a digital first experience tailored to the unique market dynamics. We're excited to answer this rapidly developing market where Micro Entrepreneurship is a central driver to their economic growth.
Brian: And make more intelligent product recommendations and subscriptions to improve customer retention and overall lifetime value.
Brian: This will further this will then further empower our brand affiliates and sales leaders to grow their intelligent beauty and wellness businesses.
James Thomas, Unknown Executive, James Thomas, Ryan Napierski
Our second priority in 2025 is to accelerate innovation with the introduction of PrismIO, our truly intelligent wellness platform. We've been preparing for this opportunity for more than 20 years of collective scientific studies and research and development.
Brian: To better understand the future I need to describe the foundation upon which prison Io has built more than $485 billion of nutritional supplements were consumed around the world in 2024 growing at six 4% per year.
Speaker Change: With recent technological advancements in machine learning and artificial intelligence we are now reaching a point of enabling us to realize this vision within a more integral way that will enhance our ability to develop even deeper relationships with our consumers.
Brian: With little to no way of knowing whether these supplements are actually improving one's overall health.
Brian: Prism Io is built upon technology, new skin first launched in 2003 with the bio photonics scanner to noninvasive Noninvasively measure carotenoid levels in the skin <unk>.
Speaker Change: and make more intelligent product recommendations and subscriptions to improve customer retention and overall lifetime value. This will then further empower our brand affiliates and sales leaders to grow their intelligent beauty and wellness businesses.
Ryan Napierski: We're excited to enter this rapidly developing market with where micro entrepreneurship is a central driver to their economic growth.
Brian: Carotenoids are an important source of antioxidants that are widely understood is a critical biomarker for fruit and vegetable intake and a key indicator of overall cellular health we have since amassed one of the world's largest antioxidant databases with more than 20 million scan across more than 50 countries, which provides us with significant.
Ryan Napierski: Our second priority in 2025 is to accelerate innovation with the introduction of PRISM-IO, our truly intelligent wellness platform. We've been preparing for this opportunity for more than 20 years of collective scientific studies and research and development. With recent technological advancements in machine learning and artificial intelligence, we are now reaching a point of enabling us to realize this vision in a more integral way that will enhance our ability to develop even deeper relationships with our consumers and make more intelligent product recommendations and subscriptions to improve customer retention and overall lifetime value. This will then further empower our brand affiliates and sales leaders to grow their intelligent beauty and wellness business.
James Thomas, Unknown Executive, James Thomas, Ryan Napierski
Speaker Change: To better understand the future, I need to describe the foundation upon which Prism at I.O. is built.
Speaker Change: More than $485 billion of nutritional supplements were consumed around the world in 2024, growing at 6.4% per year, with little to no way of knowing whether these supplements are actually improving once overall health.
Brian: Insights into the critical biomarker throughout the world.
Brian: Fast forward to 2021, when we took our euro monitor acclaimed world's number one beauty and wellness device systems and began connecting them with the launch of <unk> Io followed by age lock wells for Io or renew Spa Io with these connected devices. We have now added more than 28 million treatments from nearly 500.
Speaker Change: PrismIO is built upon technology, NU Skin first launched in 2003 with the biophotonic scanner to non-invasively measure paratnoid levels in the skin.
Speaker Change: Crohnoy's are an important source of antioxidants that are widely understood as a critical biomarker for fruit and vegetable intake and a key indicator of overall cellular health.
Brian: Devices with more than 100 million data points, providing further beauty and wellness insights into the behaviors and product usage within our Io wellness platform.
Ryan Napierski: To better understand the future, I need to describe the foundation upon which PRISM-IO is built. More than $485 billion of nutritional supplements were consumed around the world in 2024, growing at 6.4% per year, with little to no way of knowing whether these supplements are actually improving one's overall health. PRISM-io is built upon technology NU Skin first launched in 2003 with the biophotonic scanner to non-invasively measure carotenoid levels in the skin. Carotenoids are an important source of antioxidants that are widely understood as a critical biomarker for fruit and vegetable intake and a key indicator of overall cellular health.
Speaker Change: We have since amassed one of the world's largest antioxidant databases with more than 20 million scans across more than 50 countries, which provides us with significant insights into the critical biomarker throughout the world.
Brian: In 2025, we will take the next significant step in accelerating our business out of our.
Brian: Intelligent beauty excuse me, our intelligent wellness platform with the introduction of Prism Io a palm sized device that accurately measures the carotenoid levels in your skin by the fingertip to provide insight into consumers about their overall <unk> score.
Speaker Change: Fast forward to 2021 when we took our Euro Monitor acclaimed World's No. 1 Beauty and Wellness Device systems and began connecting them with the launch of Agiloc Luma Spa I.O. followed by Agiloc Wells Spa I.O. or Renew Spa I.O.
Brian: Leveraging our extensive AG science database and powerful AI capabilities, our customers can receive intelligent insights into their healthy lifestyle as well as product recommendations to improve their antioxidant score and assist an overall healthier living.
Speaker Change: With these connected devices, we have now added more than 28 million treatments from nearly 500,000 devices with more than 100 million data points providing further beauty and wellness insights in the behaviors and product usage within our IO wellness platform.
Ryan Napierski: We have since amassed one of the world's largest antioxidant databases with more than 20 million scans across more than 50 countries, which provides us with significant insights into the critical biomarker throughout the world. Fast forward to 2021, when we took our Euromonitor acclaimed world's number one beauty and wellness device systems and began connecting them with the launch of Agelok LumaSpa IO, followed by Agelok WellSpa IO or RenewSpa IO. With these connected devices, we have now added more than 28 million treatments from nearly 500,000 devices, with more than 100 million data points providing further beauty and wellness insights into behaviors and product usage within our IOWellness platform.
Brian: We will also leverage Mike macro insights from this intelligent wellness platform to develop more customized nutrition solutions for consumers based upon geographic and dietary micro nutrient needs.
Speaker Change: In 2025, we will take the next significant step in accelerating our business out of our
Speaker Change: Intelligence Beauty, our intelligent wellness platform, with the introduction of PrismIO, a Palm-sized device that accurately measures the carotenoid levels in your skin via the fingertip to provide insight into consumers about their overall antioxidant score.
Brian: We anticipate incorporating deeper insights acquired by a genetic testing from life DNA into our intelligent wellness platform as part of our next phase of development and anticipated to be in 2026 and 27.
Brian: As we further build out this holistic wellness ecosystem.
Speaker Change: Leveraging our extensive ag science database and powerful AI capabilities, our customers can receive intelligent insights into their healthy lifestyle, as well as product recommendations to improve their antioxidant score and assist in overall healthier living.
Brian: We will begin to rollout our prism Io in limited quantities for qualified sales leaders during Q3 and Q4 of this year followed by leader launches around the globe in the first half of 2026 with broader based consumer distribution thereafter, the launch of <unk> will be accompanied by re stages of our leading nutrition.
Speaker Change: We will also leverage micro-insights from this intelligent wellness platform to develop more customized nutrition solutions for consumers based upon geographic and dietary micro-nutrient needs.
Ryan Napierski: In 2025, we will take the next significant step in accelerating our business out of our intelligent wellness platform with the introduction of PRISM-IO, a palm-sized device that accurately measures the carotenoid levels in your skin via the fingertip to provide insight into consumers about their overall antioxidant score. Leveraging our extensive aging science database and powerful AI capabilities, our customers can receive intelligent insights into their healthy lifestyle, as well as product recommendations to improve their antioxidant score and assist in overall healthier living. We will also leverage macro insights from this intelligent wellness platform to develop more customized nutrition solutions for consumers based upon geographic and dietary micronutrient needs.
Brian: Lifehack line, incorporating updated formulas to meet geographic dietary needs at various pricing tiers to meet different customer segments across our developed developing and emerging markets.
James Thomas, Unknown Executive, James Thomas, Ryan Napierski
Speaker Change: We anticipate incorporating deeper insights acquired by a genetic testing from life DNA into our intelligent wellness platform as part of our next phase of development and anticipated to be in 2026 and 27 as we further build out this holistic wellness ecosystem.
Brian: As more consumers get their intelligent antioxidant score with prism Io, we anticipate nutritional supplement purchases and subscriptions will increase driving incremental revenue and retention, which will result in a greater customer lifetime value and will also provide greater opportunities for our sales force to grow their independent beauty and wellness businesses.
I'm sorry. I'm sorry. I'm sorry. I'm sorry. I'm sorry.
Speaker Change: We'll begin to roll out our Prismio and limited quantities for qualified cells leaders during Q3 and Q4 of this year, followed by leader launches around the globe in the first half of 2026, with broader base consumer distribution thereafter.
Brian: And our third priority for 2025 is improving operational performance and efficiency I am pleased with the ongoing efforts to steadily improve profitability as we deploy our product portfolio and expense optimization efforts around the world, we're making steady progress towards our improving gross margin target.
Speaker Change: The launch of Prismio will be accompanied by restages of our leading nutrition supplement life pack line, incorporating updated formulas to meet geographic dietary needs, at various pricing tiers to meet different customer segments across our developing and emerging
Ryan Napierski: We anticipate incorporating deeper insights acquired via genetic testing from life DNA into our intelligent wellness platform as part of our next phase of development anticipated to be in 2026 and 27, as we further build out this holistic wellness ecosystem. We'll begin to roll out our PRISM-IO in limited quantities for qualified sales leaders during Q3 and Q4 of this year, followed by leader launches around the globe in the first half of 2026, with broader-based consumer distribution thereafter. The launch of PRISM-IO will be accompanied by restages of our leading Nutrition Supplement Life Hack line, incorporating updated formulas to meet geographic dietary needs at various pricing tiers to meet different customer segments across our developed, developing, and emerging markets.
Brian: For the core business as well as our broader market profitability improvement efforts.
Speaker Change: As more consumers get their intelligent antioxidant score with PrismIO, we anticipate nutritional supplement purchases and subscriptions will increase.
Brian: Let me turn the time over to James now, who will dive deeper into our progress on this critical priority and to take you through our financial performance in Q1 and outlook for the remainder of this year. They will also cover how we are strengthening our balance sheet and overall financial position as we seek to improve shareholder value through steadily improving revenue performance in there.
Speaker Change: Driving Infermental Revenue and Retention, which will result in a greater customer lifetime value and will also provide greater opportunities for our Salesforce to grow their independent beauty and wellness businesses.
Speaker Change: And our third priority for 2025 is improving operational performance and efficiency.
Earnings per share James Thank you Ryan good afternoon, and thank you for joining us today for our Q1 earnings call I am pleased to provide an overview of our performance for the first quarter of the year, including key highlights challenges and our outlook for the rest of 2025 as always I will walk through the financial results touch on some key business dynamics.
Speaker Change: Please, with the ongoing efforts to steadily improve profitability as we deploy our product portfolio and expense optimization efforts around the world. We are making steady progress towards our improving growth margin target for the core business, as well as our broader market profitability improvement efforts.
Ryan Napierski: As more consumers get their Intelligent Antioxidant Score with PRISM.io, we anticipate nutritional supplement purchases and subscriptions will increase, driving incremental revenue and retention, which will result in a greater customer lifetime value, and will also provide greater opportunities for our sales force to grow their independent beauty and wellness businesses.
Brian: Discuss our outlook for Q2 and provide an update on how we're navigating the current macroeconomic environment.
James Thomas, Unknown Executive, James Thomas, Ryan Napierski
James Thomas: Let me turn the time over to James now who will dive deeper into our progress on the critical priority and to take you through our financial performance in Q1 and outlook for the remainder of this year.
Brian: I'll be speaking to adjusted non-GAAP financial measures as it pertains to our financial results reconciliations to the most directly comparable GAAP measures can be found on our Investor Relations website.
James Thomas: He'll also cover how we are strengthening our balance seat and overall financial position as we see to improve shareholder value through steadily improving revenue performance and earnings for share.
Brian: Turning to our financial results for the quarter I am pleased to report solid performance in several key areas for the first quarter. We delivered revenue at the top end of the range at $364 5 million, which included a 3% negative foreign currency impact of $12 3 million.
Ryan Napierski: And our third priority for 2025 is improving operational performance and efficiency. I'm pleased with the ongoing efforts to steadily improve profitability as we deploy our product portfolio and expense optimization efforts around the world. We're making steady progress towards our improving gross margin target for the core business as well as our broader market profitability improvement efforts.
Speaker Change: Thank you Ryan. Good afternoon and thank you for joining us today for our Q1 earnings call.
James Thomas: I'm pleased to provide an overview of our performance for the first quarter of the year, including key highlights, challenges and our outlook for the rest of 2025.
Brian: GAAP earnings per share came in at $2 14.
Brian: Whereas adjusted earnings per share came in at 23.
Ryan Napierski: Let me turn the time over to James now, who will dive deeper into our progress on this critical priority and to take you through our financial performance in Q1 and outlook for the remainder of this year. He'll also cover how we are strengthening our balance sheet and overall financial position as we seek to improve shareholder value through steadily improving revenue performance and our earnings per share.
Brian: Excluding the gain from the sale of <unk> and other charges.
Brian: This surpassed our guidance and demonstrated significant improvement over the prior year of <unk>.
Brian: Our Q1 gross margin was 67, 8% compared to 75% in the prior year, primarily due to the revenue mix between rise entities and the new skin core following the selloff natively.
James Thomas: Turning to our financial results for the quarter, I'm pleased to report solid performance in several key areas. For the first quarter, we delivered revenue at the top end of the range at $364.5 million, which included a 3% negative foreign currency impact of $12.3 million.
James Thomas: James?
James Thomas: Thank you, Ryan.
James Thomas: Good afternoon, and thank you for joining us today for our Q1 earnings call. I'm pleased to provide an overview of our performance for the first quarter of the year, including key highlights, challenges, and our outlook for the rest of 2025. As always, I'll walk through the financial results, touch on some key business dynamics, discuss our outlook for Q2, and provide an update on how we're navigating the current macroeconomic environment. I'll be speaking to adjusted non-gap financial measures as it pertains to our financial results.
Brian: Within our core Nu skin business gross margin was 76, 7% slightly down from the prior year, However, showing three quarters of sequential adjusted gross margin improvement from the new skin business. We expect this trend to continue into Q2.
James Thomas: Gap Earnings per Share came in at $2.14, whereas adjusted Earnings per Share came in at $0.23, excluding the gain from the sell of Mavily and other charges. This surpassed our guidance and demonstrated significant improvement over the prior year
Brian: Selling expense as a percentage of revenue was 32, 5% for the quarter a decline from the prior year, primarily reflecting the overall revenue mix between our quarters can business and rise within the core new skin segment selling expense was 38, 7% down from 41, 7% in the prior year.
James Thomas: Reconciliations to the most directly comparable gap measures can be found on our investor relations website. Turning to our financial results for the quarter, I'm pleased to report solid performance in several key areas. For the first quarter, we delivered revenue at the top end of the range at $364.5 million, which included a 3% negative foreign currency impact of $12.3 million. Gap earnings per share came in at $2.14, whereas adjusted earnings per share came in at $0.23, excluding the gain from the sell of Mavely and other charges. This surpassed our guidance and demonstrated significant improvement over the prior year.
James Thomas: Our Q1 gross margin was 67.8% compared to 70.5% in the prior year, primarily due to revenue mix between rise entities and the new skin core following the cell of Maybelline.
Brian: Decline was largely driven by lower sales performance in the U S, China and Southeast Asia Pacific markets due to global trade tensions and other macroeconomic pressures, we anticipate selling expense to return to our historic norm of 40% as the business strengthens around the world and the enhanced compensation plan gains adoption.
James Thomas: Within our core new skin business, Girl's Margin was 76.7%, slightly down from the prior year, however, showing three quarters of sequential adjusted Girl's Margin improvement from the new skin business. We expect this trend to continue into Q2.
Brian: General and administrative expenses improved as a percentage of revenue declined to 28, 9% from 29, 9%, reflecting cost reduction efforts and labor migration to a shared service model for technology and aligning our fixed overhead to current levels of revenue.
James Thomas: Selling Extence as a percentage of revenue was 32.5% for the quarter. A decline from the prior year, primarily reflecting the overall revenue mix between our core newskin business and rise. Within the core newskin segment, selling expense was 38.7% down from 41.7% in the prior year.
James Thomas: Our Q1 gross margin was 67.8% compared to 70.5% in the prior year, primarily due to the revenue mix between rise entities and the NU Skin core following the sell of Within our core NU Skin business, gross margin was 76.7%. slightly down from the prior year, however, showing three quarters of sequential adjusted gross margin improvement from the NU Skin business.
Brian: Adjusted operating margin for the quarter was six 4% up 250 basis points from three 8% in the prior year. Despite continued topline pressures. We believe there is still room for efficiency gains in this area as we remain disciplined in our cost management efforts.
James Thomas: The decline was largely driven by lower sales performance in the US, China, and Southeast Asia Pacific markets due to global trade tensions and other macroeconomic pressures.
James Thomas: We anticipate selling expense to return to our historic norm of 40% as the business strengthens around the world and the enhanced compensation plan gains adoption.
Brian: During the quarter, we had nonrecurring gains and other charges that we've adjusted from earnings to reflect the ongoing operations of the business in the quarter, we recorded a $176 million gain from the sale of <unk>, which was partially offset by other impairments and charges related to the operational shifts of our rise portfolio companies.
James Thomas: We expect this trend to continue into Q2. Selling expense as a percentage of revenue was 32.5% for the quarter, a decline from the prior year, primarily reflecting the overall revenue mix between our core NU Skin business and Rise. Within the core NU Skin segment, selling expense was 38.7%, down from 41.7% in the prior year. The decline was largely driven by lower sales performance in the U.S., China, and Southeast Asia Pacific markets due to global trade tensions and other macroeconomic pressures.
James Thomas: General and administrative expenses improved as a percentage of revenue declining to 28.9% from 29.9% Reflecting cost reduction efforts in labor migration to a shared service model for technology and aligning our fixed overhead the current levels of revenue
Brian: And investments.
Brian: I'd now like to turn to our balance sheet and liquidity position.
James Thomas: Adjusted operating margin for the quarter was 6.4%, up 250 basis points from 3.8% in the prior year despite continued top line pressures. We believe there is still room for efficiency gains in this area as we remain disciplined in our cost management efforts.
Brian: During the quarter, we reduced our outstanding debt by $155 million.
Brian: Bringing our total debt to $239 million.
James Thomas: We anticipate selling expense to return to our historic norm of 40% as the business strengthens around the world and the enhanced compensation plan gains adoption. General and administrative expenses improved as a percentage of revenue declining to 28.9% from 29.9%, reflecting cost reduction efforts in labor, migration to a shared service model for technology, and aligning our fixed overhead to current levels of revenue. Adjusted operating margin for the quarter was 6.4%, up 250 basis points from 3.8% in the prior year despite continued top line pressure. We believe there is still room for efficiency gains in this area, as we remain disciplined in our cost management efforts.
Brian: Our lowest level in more than 10 years, we ended the quarter with $204 million in cash marking continued progress toward our goal of achieving cash to debt neutrality in.
James Thomas: During the quarter, we had non-recurring gains and other charges that we've adjusted for our earnings to reflect the ongoing operations of the business.
Brian: In line with our disciplined capital allocation strategy, we returned approximately $8 million to shareholders comprised of $3 million in dividends and $5 million in share repurchases at quarter end, we had 157 $4 million remaining under our current share repurchase authorization.
James Thomas: In the quarter, we recorded $176 million game from the cell of Maid Lee, which was partially offset by other impairments and charges related to the operational shifts of our rise portfolio companies and investments.
James Thomas: I'd now like to turn to our balance sheet and liquidity position.
Brian: Looking ahead to the remainder of 2025, we are encouraged by improving revenue trends across developing markets. At the same time, we remain mindful of persistent global uncertainties, including the potential impact of tariffs and evolving geopolitical dynamics to mitigate risk and ensure continuous.
James Thomas: During the quarter we reduced our outstanding debt by $155 million, bringing our total debt to $239 million.
James Thomas: Our lowest level in more than 10 years. We ended the quarter with $204 million in cash, marking continued progress toward our goal of achieving cash to debt neutrality.
James Thomas: During the quarter, we had non-recurring gains and other charges that we've adjusted from earnings to reflect the ongoing operations of the business. In the quarter, we recorded $176 million gain from the sell of Mabley, which was partially offset by other impairments and charges related to the operational shifts of our RISE portfolio companies and investors.
Brian: We are implementing proactive supply chain strategies, such as diversified sourcing and optimized inventory planning while current projections suggest tariffs are unlikely to materially impact our cost in the near term. We continue to closely monitor potential effects on consumer sentiment and overall demand for new skin products.
James Thomas: At quarter end, we had $157.4 million remaining under our current share repurchase authorization.
James Thomas: I'd now like to turn to our balance sheet and liquidity position. During the quarter, we reduced our outstanding debt by $155 million, bringing our total debt to $239 million, our lowest level in more than 10 years. We ended the quarter with $204 million in cash, marking continued progress toward our goal of achieving cash-to-debt neutrality. In line with our discipline capital allocation strategy, we returned approximately $8 million to shareholders comprised of $3 million in dividends and $5 million in share repurchase. At quarter end, we had $157.4 million remaining under our current share repurchase authorization. Looking ahead to the remainder of 2025, we're encouraged by improving revenue trends across developing markets.
Brian: Given the ongoing uncertainty and limited visibility into the remainder of the year.
James Thomas: Looking ahead to the remainder of 2025, we're encouraged by improving revenue trends across developing markets.
Brian: Maintaining our current guidance with the expectation of providing more informed updates at the end of Q2, when we anticipate having clear insight into consumer behaviors and top line trends, we project second quarter revenue between $355 million and $390 million factoring in in <unk>.
James Thomas: At the same time, we remain mindful of persistent global uncertainties, including the potential impact of tariffs and evolving geopolitical dynamics to mitigate risk and ensure continuity. We are implementing proactive supply chain strategies such as diversified sourcing.
Brian: <unk> foreign currency headwind between 2% to 3% Q2 reported earnings per share is anticipated to be in the range of 20 to 30.
Brian: In conclusion we're.
Brian: We're pleased to have delivered on our Q1 guidance and remain focused on executing our strategy amid a complex global environment. Despite these challenges we remain confident in our ability to adapt and are committed to driving operational performance managing costs accelerating growth in key regions and maintaining a strong financial position we look.
James Thomas: Given the ongoing uncertainty and limited visibility into the remainder of the year, we are maintaining our current guidance with the expectation of providing more informed updates at the end of Q2 when we anticipate having clear insight into consumer behaviors and top line trends.
James Thomas: At the same time, we remain mindful of persistent global uncertainties, including the potential impact of tariffs and evolving geopolitical dynamics. To mitigate risk and ensure continuity, we are implementing proactive supply chain strategies, such as diversified sourcing and optimized inventory planning. While current projections suggest tariffs are unlikely to materially impact our costs in the near term, we continue to closely monitor potential effects on consumer sentiment and overall demand for NU Skin products.
Brian: Forward to updating you on our progress as we move through the second quarter of 2025, I will now turn the time back over to Ryan for closing comments. Thanks, James So in summary, while the operating environment remains somewhat uncertain. We remain focused on driving our critical strategic strategic priorities of number one strengthening our core nu skin business.
James Thomas: We project second quarter revenue between $355 million and $390 million, factoring in an expected foreign currency headwind between 2 to 3%. Q2 reported earnings per share is anticipated to be in the range of $0.20 to $0.30.
Brian: This to accelerate accelerating innovation with prism Io and are truly intelligent wellness platform and improve profitability to drive increasing shareholder value, we will be aligning with our amazing team of global sales leaders in June as we recognize their commitments and new skin and our mission of empowering people around the world to look fill a lift.
Inclusion
We're pleased to have delivered on our Q1 guidance.
James Thomas: Given the ongoing uncertainty and limited visibility into the remainder of the year, we are maintaining our current guidance with the expectation of providing more informed updates at the end of Q2 when we anticipate having clearer insight into consumer behaviors and top line trends. We project second quarter revenue between $355 million and $390 million, factoring in an expected foreign currency headwind between 2 to 3%. Q2 reported earnings per share is anticipated to be in the range of 20 cents to 30 cents.
James Thomas: and remain focused on executing our strategy amid a complex global environment.
James Thomas: Despite these challenges, we remain confident in our ability to adapt [inaudible]
and are committed to driving operational performance, managing costs.
James Thomas: Accelerating Growth in Key Region and maintaining a strong financial position. We look forward to updating you on our progress as we move through the second quarter of 2025.
Brian: Better lives, we're well positioned to create significant long term value on our journey to becoming the world's leading beauty wellness and lifestyle leadership opportunity platform. Thank you for joining the call and if you have questions. Please reach out to our Investor Relations team.
Brian: We will get back to you soon thank you.
James Thomas: In conclusion, we're pleased to have delivered on our Q1 guidance and remain focused on executing our strategy amid a complex global environment. Despite these challenges, we remain confident in our ability to adapt and are committed to driving operational performance, managing costs, accelerating growth in key regions, and maintaining a strong financial position. We look forward to updating you on our progress as we move through the second quarter of 2025.
Brian: This does conclude today's conference call you may all disconnect.
James Thomas: to accelerating innovation with Prism I.O. and our truly intelligent wellness platform and improve profitability and increasing shareholder value.
James Thomas: We're well positioned to create significant long-term value on our journey to becoming the world's leading beauty, wellness and lifestyle leadership opportunity platform. Thank you for joining the call and if you have questions, please reach out to our Investor Relations team.
Ryan Napierski: I will now turn the time back over to Ryan for closing comments. Thanks, James. So, in summary, while the operating environment remains somewhat uncertain, we remain focused on driving our critical strategic priorities of, number one, strengthening our core NU Skin business, two, accelerating innovation with Prism IO and our truly intelligent wellness platform, and improved profitability and increasing shareholder value. We will be aligning with our amazing team of global sales leaders in June as we recognize their commitment to NU Skin and our mission of empowering people around the world to look, feel, and live better lives.
and we'll get back to you soon. Thank you.
This does conclude today's conference call. You may all disconnect.
Ryan Napierski: We're well-positioned to create significant long-term value on our journey to becoming the world's leading beauty, wellness, and lifestyle leadership opportunity platform.
Ryan Napierski: Thank you for joining the call, and if you have questions, please reach out to our investor relations team. And we'll get back to you soon. Thank you.
Speaker Change: James Thomas, Unknown Executive, James Thomas, Ryan Napierski, James Thomas, Ryan Napierski,
Unknown Executive: This does conclude today's conference call. You may all dis...
James Thomas, Unknown Executive, James Thomas, Ryan Napierski
James Thomas, Unknown Executive, James Thomas, Ryan Napierski
James Thomas, Unknown Executive, James Thomas, Ryan Napierski
[music]
Ryan Napierski: In the early days of the year, she was the first to be released on the show, and she was the first to be released on the show
Ryan Napierski: [music].